The dysfunction of BACE1 or the accumulation of α-Synuclein are the pathological characteristic of patients with AD or PD, and siBACE1 or sisynuclein are developed to help these proteins degradation [23, 24]. This evidence concerns the gene BACE1 and Parkinson disease.